ITGAD and brain injury: It was previously reported that blocking antibodies against αD reduced neutrophil and macrophage numbers and improved cognition and other functional outcomes in experimental traumatic brain injury in rats [70, 71], suggesting that αDβ2 has broad effector activities in both sterile and infectious CNS inflammation.